Showing results (1-10 of 293) with videos related to
Sort By:
Pageof 30
Oncogene|March 17, 2018
Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensingZsofia Miskolczi, Michael P Smith, Emily J Rowling, et al.Pigment Cell & Melanoma Research|October 3, 2018
A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh /AXLlow melanomaMichael P Smith, Sareena Rana, Jennifer Ferguson, et al.Cancer Cell|March 16, 2016
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma TherapyMichael P Smith, Holly Brunton, Emily J Rowling, et al.Pigment Cell & Melanoma Research|March 8, 2020
Cooperative behaviour and phenotype plasticity evolve during melanoma progressionEmily J Rowling, Zsofia Miskolczi, Raghavendar Nagaraju, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational ToleranceMichael P Smith, Claudia WellbrockEMBO Molecular Medicine|June 14, 2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.Journal of the National Cancer Institute|December 20, 2012
Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanomaMichael P Smith, Jennifer Ferguson, Imanol Arozarena, et al.Pigment Cell & Melanoma Research|July 20, 2019
Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survivalJennifer Ferguson, Daniel J Wilcock, Sophie McEntegart, et al.Molecular Cancer Therapeutics|March 18, 2015
MGMT Expression Predicts PARP-Mediated Resistance to TemozolomideOihane Erice, Michael P Smith, Rachel White, et al.Oncotarget|April 6, 2017
Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growthJennifer Ferguson, Michael Smith, Isabel Zudaire, et al.Pageof 30